In addition, elevated Sp1 mRNA and protein levels in the cortex, hippocampus, and cerebellum of AD patients and transgenic mice exacerbate tau pathology, amyloid plaque formation, and cognitive decline (Citron et al, 2008; Citron et al, 2015; Villa et al, 2013). The gene discussed is SP1; the disease is Alzheimer disease.